---
figid: PMC7461813__fmolb-07-00202-g002
figlink: pmc/articles/PMC7461813/figure/F2/
number: F2
caption: TM4SF1 promotes the development and migration of cancer cells. TM4SF1 promotes
  cancer by modulating various biological behaviors of cancer and inhibits cancer
  cell apoptosis by regulating caspase-9, caspase-3, BCL-2, Bax, the PI3K/AKT/mTOR
  pathway, and ROS-related pathways, and promotes cell proliferation by modulating
  the PCNA, cyclin D1, and YAP-TEAD pathways. TM4SF1 interacts with collagen I and
  induces metastatic reactivation. Soluble collagen I induces DDR1 aggregation at
  the cell surface and recruitment of TM4SF1 and enhances the interaction between
  DDR1 and TM4SF1, thus forming DDR1-TM4SF1 clusters at the cell surface. TM4SF1 functions
  as a membrane adaptor connecting DDR1 to syntenin2. Then, DDR1 activates PKC and
  the JAK2/STAT3 pathway through TM4SF1-mediated non-canonical DDR1 signaling by promoting
  the activation of PKC via recruitment of syntenin-2, thus inducing transphosphorylation
  and activation of JAK2/STAT3. TM4SF1 upregulates the expression of MMP-2 and MMP-9.
  TM4SF1 can form a complex with CD13 to promote cell migration and invasion. In addition,
  TM4SF1 activates the ERK 1/2 signaling pathway. TM4SF1 is a partner of DVL2 and
  positively modulates Wnt/beta-catenin signaling by enhancing DVL2-Axin interaction.
  TM4SF1 is induced by Kras signaling, and reduction of TM4SF1 promotes the ubiquitination
  of β-catenin. ADAM23 and miR-206 regulate the expression of TM4SF1, and prostaglandin
  E2 (PGE2) significantly inhibits the expression of miR-206, while increasing the
  expression of TM4SF1. LINC00707 functions as a molecular sponge of miR-206, and
  in this way indirectly regulates the expression of TM4SF1. miR-203 and miR-141 inhibit
  EMT by regulating TM4SF1-mediated modulation of E-cadherin, CK19, and VEGF-A expression.
  TM4SF1 regulates E-cadherin expression through the AKT signaling pathway. MiR-30a/c
  inhibits cancer stem-like characteristics by regulating TM4SF1. TM4SF1 suppresses
  the transcription of the pluripotency factors Sox2 and Oct4, suggesting that TM4SF1
  promotes breast CSC traits. TM4SF1 interacts with integrins to stimulate VEGF-A
  to affect angiogenesis. TM4SF1 is associated with myosin-10 and β-actin, which are
  associated with filopodia generation. In conclusion, TM4SF1 promotes the migration
  of cancer cells by inducing EMT; enhancing self-renewal ability, tumor angiogenesis,
  and invadopodia formation; and regulating related signaling pathways.
pmcid: PMC7461813
papertitle: Role of Transmembrane 4 L Six Family 1 in the Development and Progression
  of Cancer.
reftext: Fangmei Fu, et al. Front Mol Biosci. 2020;7:202.
pmc_ranked_result_index: '12112'
pathway_score: 0.9444655
filename: fmolb-07-00202-g002.jpg
figtitle: TM4SF1 promotes the development and migration of cancer cells
year: '2020'
organisms:
- Mus musculus
- Rattus norvegicus
- Adenoviridae
- Nicotiana tabacum
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7461813__fmolb-07-00202-g002.html
  '@type': Dataset
  description: TM4SF1 promotes the development and migration of cancer cells. TM4SF1
    promotes cancer by modulating various biological behaviors of cancer and inhibits
    cancer cell apoptosis by regulating caspase-9, caspase-3, BCL-2, Bax, the PI3K/AKT/mTOR
    pathway, and ROS-related pathways, and promotes cell proliferation by modulating
    the PCNA, cyclin D1, and YAP-TEAD pathways. TM4SF1 interacts with collagen I and
    induces metastatic reactivation. Soluble collagen I induces DDR1 aggregation at
    the cell surface and recruitment of TM4SF1 and enhances the interaction between
    DDR1 and TM4SF1, thus forming DDR1-TM4SF1 clusters at the cell surface. TM4SF1
    functions as a membrane adaptor connecting DDR1 to syntenin2. Then, DDR1 activates
    PKC and the JAK2/STAT3 pathway through TM4SF1-mediated non-canonical DDR1 signaling
    by promoting the activation of PKC via recruitment of syntenin-2, thus inducing
    transphosphorylation and activation of JAK2/STAT3. TM4SF1 upregulates the expression
    of MMP-2 and MMP-9. TM4SF1 can form a complex with CD13 to promote cell migration
    and invasion. In addition, TM4SF1 activates the ERK 1/2 signaling pathway. TM4SF1
    is a partner of DVL2 and positively modulates Wnt/beta-catenin signaling by enhancing
    DVL2-Axin interaction. TM4SF1 is induced by Kras signaling, and reduction of TM4SF1
    promotes the ubiquitination of β-catenin. ADAM23 and miR-206 regulate the expression
    of TM4SF1, and prostaglandin E2 (PGE2) significantly inhibits the expression of
    miR-206, while increasing the expression of TM4SF1. LINC00707 functions as a molecular
    sponge of miR-206, and in this way indirectly regulates the expression of TM4SF1.
    miR-203 and miR-141 inhibit EMT by regulating TM4SF1-mediated modulation of E-cadherin,
    CK19, and VEGF-A expression. TM4SF1 regulates E-cadherin expression through the
    AKT signaling pathway. MiR-30a/c inhibits cancer stem-like characteristics by
    regulating TM4SF1. TM4SF1 suppresses the transcription of the pluripotency factors
    Sox2 and Oct4, suggesting that TM4SF1 promotes breast CSC traits. TM4SF1 interacts
    with integrins to stimulate VEGF-A to affect angiogenesis. TM4SF1 is associated
    with myosin-10 and β-actin, which are associated with filopodia generation. In
    conclusion, TM4SF1 promotes the migration of cancer cells by inducing EMT; enhancing
    self-renewal ability, tumor angiogenesis, and invadopodia formation; and regulating
    related signaling pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TM4SF1
  - ANPEP
  - DDR1
  - KRAS
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - PRKCA
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCQ
  - PRKCB
  - PRKCD
  - PRKCI
  - PRKCZ
  - PRKD3
  - DVL2
  - MMP9
  - AKT2
  - AKT3
  - AKT1
  - KRT19
  - ADAM23
  - SOX2
  - POU5F1
  - FOXO3
  - YY1AP1
  - JAK2
  - MMP2
  - AXIN1
  - AXIN2
  - STAT3
  - MTOR
  - PCNA
  - CDH2
  - VEGFA
  - CTNNB1
  - BAX
  - PGE2
  - eycin Di
genes:
- word: TM4SF1
  symbol: TM4SF1
  source: hgnc_symbol
  hgnc_symbol: TM4SF1
  entrez: '4071'
- word: TM4SF1
  symbol: TM4SF1
  source: hgnc_symbol
  hgnc_symbol: TM4SF1
  entrez: '4071'
- word: TM4SF1
  symbol: TM4SF1
  source: hgnc_symbol
  hgnc_symbol: TM4SF1
  entrez: '4071'
- word: CD13
  symbol: CD13
  source: hgnc_prev_symbol
  hgnc_symbol: ANPEP
  entrez: '290'
- word: DDR1
  symbol: DDR1
  source: hgnc_symbol
  hgnc_symbol: DDR1
  entrez: '780'
- word: Kras
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PKC)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC)
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: DVL2
  symbol: DVL2
  source: hgnc_symbol
  hgnc_symbol: DVL2
  entrez: '1856'
- word: MMP-9
  symbol: MMP9
  source: hgnc_symbol
  hgnc_symbol: MMP9
  entrez: '4318'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: CK19
  symbol: CK19
  source: hgnc_alias_symbol
  hgnc_symbol: KRT19
  entrez: '3880'
- word: ADAM23
  symbol: ADAM23
  source: hgnc_symbol
  hgnc_symbol: ADAM23
  entrez: '8745'
- word: Sox2
  symbol: SOX2
  source: hgnc_symbol
  hgnc_symbol: SOX2
  entrez: '6657'
- word: Oct4
  symbol: Oct4
  source: hgnc_alias_symbol
  hgnc_symbol: POU5F1
  entrez: '5460'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: FOX03a
  symbol: FOXO3A
  source: hgnc_prev_symbol
  hgnc_symbol: FOXO3
  entrez: '2309'
- word: YAP
  symbol: YAP
  source: hgnc_alias_symbol
  hgnc_symbol: YY1AP1
  entrez: '55249'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: MMP-2
  symbol: MMP2
  source: hgnc_symbol
  hgnc_symbol: MMP2
  entrez: '4313'
- word: AXin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN1
  entrez: '8312'
- word: AXin
  symbol: AXIN
  source: bioentities_symbol
  hgnc_symbol: AXIN2
  entrez: '8313'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PCNA
  symbol: PCNA
  source: hgnc_symbol
  hgnc_symbol: PCNA
  entrez: '5111'
- word: N-cadherin
  symbol: CDH2
  source: hgnc_symbol
  hgnc_symbol: CDH2
  entrez: '1000'
- word: VEGF-A
  symbol: VEGF-A
  source: hgnc_alias_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: beta-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: Bax
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
chemicals:
- word: PGE2
  source: MESH
  identifier: D015232
- word: eycin Di
  source: MESH
  identifier: C076868
diseases: []
figid_alias: PMC7461813__F2
redirect_from: /figures/PMC7461813__F2
figtype: Figure
---
